Cargando…

Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study

BACKGROUND: This study aimed to explore the pattern of locoregional recurrence after surgery in patients with non-metastatic stage pT4 sigmoid colon cancer and the role of adjuvant radiotherapy on survival. METHODS: We retrospectively analyzed data from 208 patients who underwent surgery in our hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yaobin, Liu, Shan, Hong, Liang, Shao, Lingdong, Wu, Junxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107167/
https://www.ncbi.nlm.nih.gov/pubmed/35562804
http://dx.doi.org/10.1186/s13014-022-02064-9
_version_ 1784708431350857728
author Lin, Yaobin
Liu, Shan
Hong, Liang
Shao, Lingdong
Wu, Junxin
author_facet Lin, Yaobin
Liu, Shan
Hong, Liang
Shao, Lingdong
Wu, Junxin
author_sort Lin, Yaobin
collection PubMed
description BACKGROUND: This study aimed to explore the pattern of locoregional recurrence after surgery in patients with non-metastatic stage pT4 sigmoid colon cancer and the role of adjuvant radiotherapy on survival. METHODS: We retrospectively analyzed data from 208 patients who underwent surgery in our hospital. The patients were randomly divided into training and validation groups at a 1:1 ratio. Patients at high risk for locoregional recurrence were screened using Cox regression analysis. Based on the data of 2,886 patients in the Surveillance, Epidemiology, and End Results (SEER) database, the effect of adjuvant radiotherapy on overall survival (OS) and cancer-specific survival (CSS) was evaluated by Kaplan–Meier curves. RESULTS: Of the 208 patients, 57 (27.4%) presented with locoregional recurrences (14 anastomotic and 43 abdominal or pelvic lymph node recurrences). Multivariate analysis showed that serum CEA, differentiation, lymph node dissection number, and N stage were independent predictors of locoregional recurrence-free survival (all p < 0.05). A risk-stratification model was constructed, and a total score of ≥ 6.5 points was considered the high-risk group for locoregional recurrence. Both the training and validation sets presented that the model had a good predictive ability (area under the curve = 0.828 and 0.724, respectively). Analysis of SEER data revealed that adjuvant radiotherapy significantly prolonged OS and CSS in the high-risk population (all p < 0.05, vs. no radiotherapy). CONCLUSIONS: Patients with a total risk score of 6.5 or more had a high likelihood of locoregional recurrence, and perhaps adjuvant radiotherapy could improve their survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02064-9.
format Online
Article
Text
id pubmed-9107167
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91071672022-05-15 Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study Lin, Yaobin Liu, Shan Hong, Liang Shao, Lingdong Wu, Junxin Radiat Oncol Research BACKGROUND: This study aimed to explore the pattern of locoregional recurrence after surgery in patients with non-metastatic stage pT4 sigmoid colon cancer and the role of adjuvant radiotherapy on survival. METHODS: We retrospectively analyzed data from 208 patients who underwent surgery in our hospital. The patients were randomly divided into training and validation groups at a 1:1 ratio. Patients at high risk for locoregional recurrence were screened using Cox regression analysis. Based on the data of 2,886 patients in the Surveillance, Epidemiology, and End Results (SEER) database, the effect of adjuvant radiotherapy on overall survival (OS) and cancer-specific survival (CSS) was evaluated by Kaplan–Meier curves. RESULTS: Of the 208 patients, 57 (27.4%) presented with locoregional recurrences (14 anastomotic and 43 abdominal or pelvic lymph node recurrences). Multivariate analysis showed that serum CEA, differentiation, lymph node dissection number, and N stage were independent predictors of locoregional recurrence-free survival (all p < 0.05). A risk-stratification model was constructed, and a total score of ≥ 6.5 points was considered the high-risk group for locoregional recurrence. Both the training and validation sets presented that the model had a good predictive ability (area under the curve = 0.828 and 0.724, respectively). Analysis of SEER data revealed that adjuvant radiotherapy significantly prolonged OS and CSS in the high-risk population (all p < 0.05, vs. no radiotherapy). CONCLUSIONS: Patients with a total risk score of 6.5 or more had a high likelihood of locoregional recurrence, and perhaps adjuvant radiotherapy could improve their survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02064-9. BioMed Central 2022-05-13 /pmc/articles/PMC9107167/ /pubmed/35562804 http://dx.doi.org/10.1186/s13014-022-02064-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lin, Yaobin
Liu, Shan
Hong, Liang
Shao, Lingdong
Wu, Junxin
Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title_full Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title_fullStr Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title_full_unstemmed Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title_short Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
title_sort postoperative locoregional recurrence pattern and treatment management of stage pt4 sigmoid colon cancer: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107167/
https://www.ncbi.nlm.nih.gov/pubmed/35562804
http://dx.doi.org/10.1186/s13014-022-02064-9
work_keys_str_mv AT linyaobin postoperativelocoregionalrecurrencepatternandtreatmentmanagementofstagept4sigmoidcoloncanceraretrospectivecohortstudy
AT liushan postoperativelocoregionalrecurrencepatternandtreatmentmanagementofstagept4sigmoidcoloncanceraretrospectivecohortstudy
AT hongliang postoperativelocoregionalrecurrencepatternandtreatmentmanagementofstagept4sigmoidcoloncanceraretrospectivecohortstudy
AT shaolingdong postoperativelocoregionalrecurrencepatternandtreatmentmanagementofstagept4sigmoidcoloncanceraretrospectivecohortstudy
AT wujunxin postoperativelocoregionalrecurrencepatternandtreatmentmanagementofstagept4sigmoidcoloncanceraretrospectivecohortstudy